Abrégé

Disclosed herein are methods of treatment and methods of evaluating individuals to identify and measure biomarkers and/or states of the individuals indicative of drug responsiveness to one or more 5-HT receptor agonist.

Classes IPC  ?

• A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
• A61B 5/16 - Dispositifs pour la psychotechnieTest des temps de réaction
• A61K 31/675 - Composés du phosphore ayant l'azote comme hétéro-atome d'un cycle, p. ex. phosphate de pyridoxal
• A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
• G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides

Abrégé

Disclosed herein are systems and methods for affecting well-being. The systems and methods may comprise receiving data, processing data, and initializing one or more models to identify a state of a user's well-being.

Classes IPC  ?

• G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
• G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques
• G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
• G16H 20/70 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mentales, p. ex. la thérapie psychologique ou le training autogène
• G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients

Abrégé

Disclosed herein are compositions comprising amorphous psilocybin. The amorphous psilocybin may be a synthetic, a-polymorphic psilocybin. Also disclosed herein are methods of treatment using amorphous psilocybin and methods of manufacturing amorphous psilocybin.

Classes IPC  ?

• C07F 9/572 - Cycles à cinq chaînons
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/19 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres lyophilisées
• A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
• A61K 31/675 - Composés du phosphore ayant l'azote comme hétéro-atome d'un cycle, p. ex. phosphate de pyridoxal

Abrégé

Disclosed herein are compositions comprising amorphous psilocybin. The amorphous psilocybin may be a synthetic, a-polymorphic psilocybin. Also disclosed herein are methods of treatment using amorphous psilocybin and methods of manufacturing amorphous psilocybin.

Classes IPC  ?

• C07F 9/572 - Cycles à cinq chaînons
• A61K 9/19 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres lyophilisées
• A61K 31/675 - Composés du phosphore ayant l'azote comme hétéro-atome d'un cycle, p. ex. phosphate de pyridoxal
• A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine

Abrégé

Provided herein are novel lisuride compounds, processes for their preparation, compositions comprising said compounds, and use in therapy. More particularly, the present disclosure relates to fluorinated and/or deuterated analog useful in the treatment of diseases, disorders or conditions treatable by modulating ther 5-HT2 receptor subtypes.

Classes IPC  ?

• C07D 471/06 - Systèmes condensés en péri
• A61K 31/4745 - QuinoléinesIsoquinoléines condensées en ortho ou en péri avec des systèmes hétérocycliques condensées avec des systèmes cycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. phénanthrolines

Abrégé

Provided herein are heterocyclic compounds, processes for their preparation, compositions comprising said compounds, and use in therapy. More particularly, the present disclosure relates to fluorinated and/or deuterated analog useful in the treatment of diseases, disorders or conditions treatable by modulating the 5-HT2 receptor subtypes.

Classes IPC  ?

• C07D 487/04 - Systèmes condensés en ortho
• C07D 471/14 - Systèmes condensés en ortho
• C07D 487/14 - Systèmes condensés en ortho

Abrégé

Disclosed herein are methods of treating neuropsychiatric and cognitive conditions in individuals by titrating a 5-HT receptor agonist over a period of time to provide a therapeutic effective amount of the 5-HT receptor agonist to the individual.

Classes IPC  ?

• G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
• A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
• A61B 5/378 - Stimuli visuels
• A61K 31/675 - Composés du phosphore ayant l'azote comme hétéro-atome d'un cycle, p. ex. phosphate de pyridoxal
• A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
• G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques

Abrégé

Disclosed herein are compositions comprising amorphous psilocybin. The amorphous psilocybin may be a synthetic, a-polymorphic psilocybin. Also disclosed herein are methods of treatment using amorphous psilocybin and methods of manufacturing amorphous psilocybin.

Classes IPC  ?

• C07F 9/572 - Cycles à cinq chaînons
• A61K 9/19 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres lyophilisées
• A61K 31/675 - Composés du phosphore ayant l'azote comme hétéro-atome d'un cycle, p. ex. phosphate de pyridoxal
• A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
• A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine

Abrégé

Disclosed herein are methods of treatment and methods of evaluating individuals to identify and measure biomarkers and/or states of the individuals indicative of drug responsiveness to one or more 5-HT receptor agonist.

Classes IPC  ?

• A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
• A61B 5/16 - Dispositifs pour la psychotechnieTest des temps de réaction
• A61B 5/369 - Électroencéphalographie [EEG]
• A61K 31/675 - Composés du phosphore ayant l'azote comme hétéro-atome d'un cycle, p. ex. phosphate de pyridoxal
• C07F 9/572 - Cycles à cinq chaînons

Abrégé

Disclosed herein are systems and methods for affecting well-being. The systems and methods may comprise receiving data, processing data, and initializing one or more models to identify a state of a user's well-being.

Classes IPC  ?

• G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
• G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
• G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients

Abrégé

Disclosed herein are compositions and methods of treating neuropsychiatric and cognitive conditions with single, repeat and/or extended release 5-HT receptor agonist dosage forms.

Classes IPC  ?

• A61K 31/661 - Acides du phosphore ou leurs esters n'ayant pas de liaison P-C, p. ex. fosfosal, dichlorvos, malathion
• A61K 31/404 - Indoles, p. ex. pindolol
• A61P 25/22 - Anxiolytiques
• A61P 25/24 - Antidépresseurs

Abrégé

Provided herein are novel lisuride compounds, processes for their preparation, compositions comprising said compounds, and use in therapy. More particularly, the present disclosure relates to fluorinated and/or deuterated analog useful in the treatment of diseases, disorders or conditions treatable by modulating ther 5-HT2 receptor subtypes.

Classes IPC  ?

• C07D 457/12 - Atomes d'azote
• A61K 31/48 - Dérivés de l'ergoline, p. ex. acide lysergique, ergotamine

Abrégé

Disclosed herein are methods for managing disorders or conditions, or treating symptoms of disorders or conditions, comprising administering 5HT receptor agonists. Also disclosed herein are pharmaceutical compositions, formulations. and dosage forms of 5HT receptor agonists.

Classes IPC  ?

• A61K 31/675 - Composés du phosphore ayant l'azote comme hétéro-atome d'un cycle, p. ex. phosphate de pyridoxal
• A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
• A61K 31/05 - Phénols
• A61K 31/12 - Cétones
• A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
• A61K 31/38 - Composés hétérocycliques ayant le soufre comme hétéro-atome d'un cycle
• A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
• A61K 31/4164 - 1,3-Diazoles
• A61K 31/422 - Oxazoles non condensés et contenant d'autres hétérocycles
• A61K 31/4439 - Pyridines non condenséesLeurs dérivés hydrogénés contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'azote comme hétéro-atome du cycle, p. ex. oméprazole
• A61K 31/454 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'azote comme hétéro-atome du cycle, p. ex. pimozide, dompéridone
• A61K 31/48 - Dérivés de l'ergoline, p. ex. acide lysergique, ergotamine
• A61K 31/496 - Pipérazines non condensées contenant d'autres hétérocycles, p. ex. rifampine, thiothixène ou sparfloxacine
• A61K 31/5415 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec au moins un azote et au moins un soufre comme hétéro-atomes d'un cycle, p. ex. sulthiame condensés en ortho ou en péri avec des systèmes carbocycliques, p. ex. phénothiazine, chlorpromazine, piroxicam
• A61K 31/5513 - 1,4-Benzodiazépines, p. ex. diazépam
• A61K 31/554 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à sept chaînons, p. ex. azélastine, pentylènetétrazole ayant au moins un azote et au moins un soufre comme hétéro-atomes d'un cycle, p. ex. clothiapine, diltiazem
• A61K 31/573 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes substitués en position 17 bêta par une chaîne à deux atomes de carbone, p. ex. prégnane ou progestérone substitués en position 21, p. ex. cortisone, dexaméthasone, prednisone ou aldostérone
• A61K 31/685 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols un des composés hydroxylés ayant des atomes d'azote, p. ex. phosphatidylsérine, lécithine
• A61K 33/06 - Aluminium, calcium ou magnésiumLeurs composés
• A61K 36/258 - Panax (ginseng)

Abrégé

Provided herein are heterocyclic compounds, processes for their preparation, compositions comprising said compounds, and use in therapy. More particularly, the present disclosure relates to fluorinated and/or deuterated analog useful in the treatment of diseases, disorders or conditions treatable by modulating the 5-HT2 receptor subtypes.

Classes IPC  ?

• C07D 487/04 - Systèmes condensés en ortho
• A61K 31/55 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à sept chaînons, p. ex. azélastine, pentylènetétrazole
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
• C07D 487/14 - Systèmes condensés en ortho

Abrégé

Disclosed herein are methods of treating neuropsychiatric and cognitive conditions in individuals by titrating a 5-HT receptor agonist over a period of time to provide a therapeutic effective amount of the 5-HT receptor agonist to the individual.

Classes IPC  ?

• A61K 31/675 - Composés du phosphore ayant l'azote comme hétéro-atome d'un cycle, p. ex. phosphate de pyridoxal
• A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
• C07D 209/16 - Tryptamines
• C07F 9/572 - Cycles à cinq chaînons
• G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
• A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
• A61B 5/16 - Dispositifs pour la psychotechnieTest des temps de réaction
• A61B 5/24 - Détection, mesure ou enregistrement de signaux bioélectriques ou biomagnétiques du corps ou de parties de celui-ci

Abrégé

Provided herein are methods and related compositions for treating or managing a mental, a behavioral, or a neuropsychiatric condition, or the symptoms thereof in an individual in need thereof, wherein the composition comprises one or more 5-HT receptor agonists, such as lysergic acid diethylamide (LSD), dimethyltryptamine (DMT), psilocybin, and psilocin, or a pharmaceutically acceptable salt, or solvate thereof. In certain embodiments, such methods involve the administration of one or more 5-HT agonist in amounts or levels that is enough to provide a therapeutic effect, but insufficient to provide an adverse effect.

Classes IPC  ?

• A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
• A61P 25/24 - Antidépresseurs
• C07D 209/16 - Tryptamines

Produits et services

Custom manufacture for others of psychedelic-based pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products namely, central nervous system health care products used to improve, treat, and prevent mental health diseases, disorders, conditions, and ailments in humans; Custom manufacture for others of psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to treat mental conditions, illnesses, and disorders in humans Psychedelic-based pharmaceuticals, pharmaceutical preparations and products for the treatment of central nervous system conditions, illnesses, and disorders in humans; psychedelic-based medicines for the treatment of central nervous system conditions, illnesses, and disorders; neurogenerative psychedelic-based pharmaceutical drugs for use in humans; serotonin receptor agonists and antagonist pharmaceutical drugs for use in humans; abuse deterrent products, namely, very low-dose, low dose, and extended release psychedelic-based pharmaceutical preparations to avoid overdosing or diversion of psychedelic drugs; psychedelic-based pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms, namely, motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, behavior; therapeutics for the treatment of mental conditions, illnesses, and disorders in humans Downloadable computer applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable computer applications for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable computer software applications for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical systems comprising software and/or hardware for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical systems comprising software and/or hardware for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable software as a Medical Device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable software as a Medical Device (SaMD) for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable software as a Medical Device (SaMD) for stimulating nerves during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans Electroencephalogram (EEG) devices namely electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical devices for monitoring, sensing, measuring, and training brain and neural activity; medical devices in the nature of elecroencephalogram (EEG), electrocardiogram (EKG), magnetoencephalogram (MEG), functional near-infrared spectroscopy (fNRIS), positron emission tomography (PET), transcranial functional ultrasound, imaging devices, pupillometers, voltmeters, photodiodes, complementary metal-oxide semiconductor (CMOS), ultrasound, piezoelectric resonant devices, lead zirconate titanate (PZT), capacitive micromachined ultrasonic transducer (CMUT), micromembrane ultrasound transducer (PMUT), auditory stimulating devices, visual stimulating devices, sleep monitoring devices, thermometers, heart monitors, blood pressure monitors for use in therapy of cognitive states to monitor, sense, or measure cognitive impairment during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical devices for stimulating nerves during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical device used for treating of mental health disorders noninvasively, namely, nodes, headsets, eyewear, probes, computers, tablets, hand-held, mobile and smart phones, smart watches, wrist monitors, body monitors, including implants, body bands, rings and sleeves, fitness trackers for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; tamper resistant dosage dispensers for administering psychedelic-based medicine to human patients Wholesale distributorship featuring psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments in humans; developing marketing strategies for others in the field of psychedelic-based pharmaceuticals, drugs, and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments in humans; wholesale distributorship featuring distribution and sale of psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to treat mental conditions, illnesses, and disorders in humans; developing marketing strategies for others in the field of psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to treat mental conditions, illnesses, and disorders in humans Warehousing services, namely, distribution of psychedelic-based pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products, namely, central nervous system health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments in humans; Distribution services, namely, delivery of psychedelic-based pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products, namely, central nervous pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products, namely, central nervous system health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments in humans Education services, namely providing computer training for brain and neural activity, providing information regarding psychiatric therapies and pharmacology in the field of psychedelic-based mental health treatments for humans Psychedelic-based pharmaceutical research and development for humans; psychedelic-based pharmaceutical drug development for humans; psychedelic-based pharmaceutical research and development in the field of mental health treatments for humans; psychedelic-based drug discovery services for humans; consultancy pertaining to pharmacology in the field of psychedelic-based mental health treatments in humans; psychedelic-based medical research in the field of human mental health conditions, illnesses, and disorders; neuropsychiatric drug discovery services including pre-clinical and clinical pharmaceutical psychedelic-based drug development for humans; psychedelic-based pharmaceutical drug development and discovery including new chemical entities, neurogenerative drugs, serotonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms in humans Licensing of proprietary information in the field of psychedelic-based pharmaceuticals, drugs, therapies, and health care products used to improve, treat, and prevent mental health diseases, disorders, conditions, illnesses, and ailments

Produits et services

Custom manufacture for others of pharmaceuticals, pharmaceutical drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; custom manufacture for others of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to treat mental conditions, illnesses and disorders International Class 005: Pharmaceutical preparations for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical products for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical preparations for the treatment of mental conditions, illnesses, and disorders; pharmaceutical drugs for the treatment of mental conditions, illnesses, and disorders; psychedelic pharmaceuticals for the treatment of central nervous system conditions, illnesses, and disorders; psychedelic-based medicines for the treatment of central nervous system conditions, illnesses, and disorders; neurogenerative pharmaceutical drugs; serotonin receptor agonists and antagonist pharmaceutical drugs; drug abuse deterrent products in the nature of low-dose pharmaceutical preparations and products, very low-dose pharmaceutical preparations and products, extended release pharmaceutical preparations and products, and tamper resistant pharmaceutical preparations and products; pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms, namely, motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, and/or behavior; pharmaceutical preparations and products for the treatment of mental conditions, illnesses, and disorders; Downloadable computer applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer applications for use in therapy of cognitive states; downloadable computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer software applications for use in therapy of cognitive states; medical systems comprising recorded and downloadable software and/or hardware for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical systems comprising recorded and downloadable software and/or hardware for use in therapy of cognitive states; downloadable software as a Medical Device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable software as a Medical Device (SaMD) for use in therapy of cognitive states; downloadable software as a Medical Device (SaMD) for stimulating nerves Electroencephalogram (EEG) devices, namely, electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes; medical devices for monitoring, sensing, measuring, and training brain and neural activity; medical devices for use in therapy of cognitive states, namely, to monitor, sense, or measure cognitive impairment; medical devices for stimulating nerves; medical device used for treating of mental health disorders non-invasively, namely, comprising a sensor for monitoring and measuring brain and neural activity; medical device used for treating of mental health disorders non-invasively, namely, for monitoring, sensing, stimulating, measuring, and training brain and neural activity Wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses and disorders Warehousing services namely, storage, distribution, pick-up and packing for shipment of pharmaceuticals, pharmaceutical drugs, therapeutics, and health care products, namely, central nervous system health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments Pharmaceutical research and development; pharmaceutical drug development; pharmaceutical research and development in the field of mental health treatments; drug discovery services; consultancy pertaining to pharmacology; medical research in the field of mental health conditions, illnesses, and disorders; neuropsychiatric drug discovery services, including pre-clinical and clinical pharmaceutical drug development; pharmaceutical drug development and discovery relating to new chemical entities, neurogenerative drugs, serotonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms Licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses, and disorders

Produits et services

(1) Pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of mental conditions, illnesses and disorders; drugs for the treatment of mental conditions, illnesses and disorders; psychedelic pharmaceuticals; psychedelic-based medicines; neurogenerative drugs; serotonin receptor agonists and antagonist drugs; abuse deterrent products; pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms; therapies for the treatment of mental conditions, illnesses and disorders. (2) Downloadable applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; Downloadable applications for use in therapy of cognitive states; Computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; Computer software applications for use in therapy of cognitive states; medical systems for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical systems for use in therapy of cognitive states; downloadable software as a Medical Device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable software as a Medical Device (SaMD) for use in therapy of cognitive states; downloadable software as a Medical Device (SaMD) for stimulating nerves. (3) Electroencephalogram (EEG) devices; medical devices for monitoring, sensing, measuring and training brain and neural activity; medical devices for use in therapy of cognitive states; medical devices for stimulating nerves; device used for treating of mental health disorders non-invasively; combination of a device used for treating mental health disorders non-invasively plus pharmaceutical preparations. (1) Operation of a pharmaceutical business, namely, distribution and sale of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; commercialization of pharmaceuticals, drugs, therapies and health care products namely, selling, distributing, developing marketing strategies in the field of pharmaceuticals, drugs, and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; operation of a pharmaceutical business, namely, distribution and sale of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders; commercialization of pharmaceuticals, drugs, and health care products namely, selling, distributing, developing marketing strategies in the field of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders. (2) Production of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; production of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders. (3) Pharmaceutical research and development; drug development; pharmaceutical research and development in the field of mental health treatments; drug discovery; pharmacology; psychedelic pharmaceutical company; research in the field of mental health conditions, illnesses and disorders; neuropsychiatric drug discovery including pre-clinical and clinical drug development; drug development and discovery including new chemical entities, neurogenerative drugs, seretonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms. (4) Licensing of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; licensing of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders.

Produits et services

(1) Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases and mental health disorders; pharmaceutical products for the treatment of central nervous system [CNS] diseases and mental health disorders; pharmaceutical preparations for the treatment of mental health disorders; pharmaceutical drugs for the treatment of mental health disorders; psychedelic pharmaceuticals for the treatment of central nervous system [CNS] diseases and mental health disorders; psychedelic-based medicines pharmaceuticals for the treatment of central nervous system [CNS] diseases and mental health disorders; neurogenerative drugs pharmaceuticals for the treatment of central nervous system [CNS] diseases and mental health disorders; serotonin receptor agonists and antagonist drugs pharmaceuticals for the treatment of central nervous system [CNS] diseases and mental health disorders; abuse deterrent products; pharmaceutical preparations for managing a mental, a behavioural, or a neuropsychiatric condition, or its symptoms, namely motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, behaviour; pharmaceutical preparations for use in psychedelic therapies for the treatment of mental health disorders (2) Downloadable applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; computer software applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; medical alert response systems for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical alert response systems for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a medical device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable software as a medical device (SaMD) for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a medical device (SaMD) for stimulating nerves (3) Electroencephalogram (EEG) devices, namely electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes during use of pharmaceuticals; medical devices for monitoring, sensing, measuring and training brain and neural activity; medical devices for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; medical devices for stimulating nerves; medical device used for treating of mental health disorders non-invasively for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical device used in combination with pharmaceutical preparations for treating mental health disorders non-invasively namely, for monitoring, sensing, stimulating, measuring, and training brain and neural activity (1) Operation of a pharmaceutical business, namely, wholesale distribution and sale of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; commercialization of pharmaceuticals, drugs, therapies and health care products namely, selling, sample distribution for others, developing of marketing strategies for others in the field of pharmaceuticals, drugs, and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; operation of a pharmaceutical business, namely, wholesale distribution and sale of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders; commercialization of pharmaceuticals, drugs, and health care products namely, selling, sample distribution for others, developing of marketing strategies for others in the field of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders (2) Custom manufacture of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; custom manufacture of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders (3) Pharmaceutical research and development; pharmaceutical drug development services; pharmaceutical research and development in the field of mental health treatments; drug discovery; consultancy pertaining to pharmacology; psychedelic pharmaceutical drug research and psychedelic pharmaceutical drug development in the field of mental health conditions, illnesses and disorders; research in the field of mental health conditions, illnesses and disorders; neuropsychiatric drug discovery including pre-clinical and clinical drug development; pharmaceutical drug development services and discovery including new chemical entities, neurogenerative drugs, seretonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms (4) Licensing of intellectual property in the field of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; licensing of intellectual property in the field of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders

Abrégé

Provided herein are methods and compositions for the treatment of psychological, cognitive, behavioral, and/or mood disorders, the composition comprising a 5HT agonist (e.g. psilocybin). In certain embodiments, such compositions are administered in amounts or levels high enough to provide a therapeutic effect, but insufficient to provide an adverse effect.

Classes IPC  ?

• A61K 31/675 - Composés du phosphore ayant l'azote comme hétéro-atome d'un cycle, p. ex. phosphate de pyridoxal
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
• C07F 9/572 - Cycles à cinq chaînons